106 related articles for article (PubMed ID: 8464231)
1. Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis.
Knulst AC; Adriaansen HJ; Hählen K; Stigter JC; van den Beemd MW; Hagemeijer A; van Dongen JJ; Hooijkaas H
Leukemia; 1993 Apr; 7(4):532-6. PubMed ID: 8464231
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias.
Consolini R; Scamardella F; Legitimo A; Putti C; Granchi D; Paolucci P; Lippi A; Guazzelli C; Acquaviva A; Rosanda C
Haematologica; 1993; 78(5):297-305. PubMed ID: 8314159
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
5. Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation.
Smedmyr B; Bengtsson M; Jakobsson A; Simonsson B; Oberg G; Tötterman TH
Eur J Haematol; 1991 Mar; 46(3):146-51. PubMed ID: 1826271
[TBL] [Abstract][Full Text] [Related]
6. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
8. Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.
Adriaansen HJ; van Dongen JJ; Kappers-Klunne MC; Hählen K; van 't Veer MB; Wijdenes-de Bresser JH; Holdrinet AC; Harthoorn-Lasthuizen EJ; Abels J; Hooijkaas H
Leukemia; 1990 Jun; 4(6):404-10. PubMed ID: 2359340
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
10. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.
Maitra A; McKenna RW; Weinberg AG; Schneider NR; Kroft SH
Am J Clin Pathol; 2001 Jun; 115(6):868-75. PubMed ID: 11392884
[TBL] [Abstract][Full Text] [Related]
11. [Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)].
Welte K; Ebener U; Hinderfeld L; Ritter J; Henze G; Kornhuber B
Klin Padiatr; 1981 May; 193(3):165-71. PubMed ID: 6943391
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal studies after bone marrow transplantation for leukaemia in children.
van den Berg H; Beverstock G; Westerhof JP; Vossen JM
Bone Marrow Transplant; 1991 May; 7(5):335-42. PubMed ID: 2070142
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia.
Todisco E; Gaipa G; Biagi E; Bonamino M; Gramigna R; Introna M; Biondi A
Leukemia; 2002 Oct; 16(10):2046-54. PubMed ID: 12357356
[TBL] [Abstract][Full Text] [Related]
16. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression.
Lavabre-Bertrand T; Janossy G; Ivory K; Peters R; Secker-Walker L; Porwit-MacDonald A
Cytometry; 1994 Dec; 18(4):209-17. PubMed ID: 7895527
[TBL] [Abstract][Full Text] [Related]
17. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
Klujber V; Koós R; Schuler D; Bocsi J
Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
[TBL] [Abstract][Full Text] [Related]
18. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow cellularity in acute lymphoblastic leukemia of children].
Styczyński J; Kubicka M; Langer B; Wysocki M; Debski R; Wolska E; Polańska M
Wiad Lek; 2000; 53(9-10):507-12. PubMed ID: 11148917
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
